Semarion
Generated by Meeveem AI
"Engineering barcoded microcarriers that transform adherent cells into assay-ready reagents"
Cambridge
•1 - 10 Employees
•Diagnostics
About Semarion
Semarion builds SemaCyte microcarriers, barcoded micro-wells that carry adherent cells in uniform geometry. Created through microchip-style microfabrication, these microcarriers transform cells into assay-ready reagents that move with liquid handling, control magnetically, cryopreserve, and decode by optical barcodes. The technology multiplexes cell models in a single well, reducing plates, reagents, and imaging time. The company addresses bottlenecks in drug discovery where adherent cell assays remain difficult to batch and automate. By combining precision microfabrication with cell biology, Semarion helps pharmaceutical teams generate better data faster for medicines targeting high unmet clinical needs.
6
Team Members
2018
Founded
Diagnostics
Sector
Hybrid
Work Environment
Our Vision
Adherent cell biology becomes as batchable, automation-ready, and reproducible as suspension workflows, making high-content screening more comparable across experiments while eliminating time, cost, and variability barriers.
Our Mission
At Semarion, our mission is to accelerate in vitro drug discovery by removing bottlenecks in adherent cell screening, helping teams generate better data faster by making assays easier to standardise, automate, and scale.